Covid-19 vaccine approvals and stock market returns : the case of Chinese stocks
Year of publication: |
2022
|
---|---|
Authors: | Ho, Ken C. ; Gao, Yibo ; Gu, Qiying ; Yang, Da |
Published in: |
Economics letters. - Amsterdam [u.a.] : Elsevier, ISSN 0165-1765, ZDB-ID 717210-2. - Vol. 215.2022, p. 1-4
|
Subject: | COVID-19 | Stock market returns | Vaccine news | Kapitaleinkommen | Capital income | Aktienmarkt | Stock market | Coronavirus | Impfung | Vaccination | China | Arzneimittel | Pharmaceuticals |
-
Ho, Ken C., (2024)
-
COVID-19 pandemic, stock returns, and volatility : the role of the vaccination program in Canada
Apergēs, Nikolaos, (2022)
-
The impact of COVID-19 vaccination on stock markets : a comparative analysis of the USA and China
Zeren, Feyyaz, (2023)
- More ...
-
Ho, Ken C., (2024)
-
The fundamental effects of ESG disclosure quality in boosting the growth of ESG investing
Wen, Hui, (2022)
-
Accounting for the “uncounted” workers : a dialectical view of accounting through Rancière
Yang, Da, (2020)
- More ...